Izotropic Corporation
IZO
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 818.10K | 1.07M | 572.10K | 1.01M | 1.88M |
| Depreciation & Amortization | 40.80K | 42.00K | 43.70K | 43.40K | 40.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.42M | 1.74M | 1.20M | 1.83M | 3.06M |
| Operating Income | -1.42M | -1.74M | -1.20M | -1.83M | -3.06M |
| Income Before Tax | -1.39M | -1.72M | -1.16M | -2.08M | -3.34M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.39 | -1.72 | -1.16 | -2.08 | -3.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.39M | -1.72M | -1.16M | -2.08M | -3.34M |
| EBIT | -1.42M | -1.74M | -1.20M | -1.83M | -3.06M |
| EBITDA | -1.40M | -1.72M | -1.17M | -1.80M | -3.03M |
| EPS Basic | -0.03 | -0.03 | -0.02 | -0.04 | -0.06 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.04 |
| EPS Diluted | -0.03 | -0.03 | -0.02 | -0.04 | -0.06 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.04 |
| Average Basic Shares Outstanding | 222.56M | 218.98M | 214.90M | 211.09M | 208.31M |
| Average Diluted Shares Outstanding | 222.56M | 218.98M | 214.90M | 211.09M | 208.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
